Insulin Glargine and (A21Gly, DiD-Arg) Insulin Do Not Promote Breast Cancer Growth in a Mouse Model

被引：0
|
作者：
Gallagher, Emily J.
Tennagels, Norbert
Werner, Ulrich
Leroith, Derek
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1915-P
引用
收藏
页码：A493 / A493
页数：1
相关论文
共 41 条
  • [31] Comparison of Radioimmuno and Carbon Nanotube Field-Effect Transistor Assays for Measuring Insulin-Like Growth Factor-1 in a Preclinical Model of Human Breast Cancer
    Jones, Laundette P.
    Stefansson, Steingrimur
    Kim, Man S.
    Ahn, Saeyoung N.
    JOURNAL OF NANOBIOTECHNOLOGY, 2011, 9
  • [32] Recombinant PAPP-A resistant insulin-like growth factor binding protein 4 (dBP4) inhibits angiogenesis and metastasis in a murine model of breast cancer
    Smith, Y. E.
    Toomey, S.
    Napoletano, S.
    Kirwan, G.
    Schadow, C.
    Chubb, A. J.
    Mikkelsen, J. H.
    Oxvig, C.
    Harmey, J. H.
    BMC CANCER, 2018, 18
  • [33] Recombinant PAPP-A resistant insulin-like growth factor binding protein 4 (dBP4) inhibits angiogenesis and metastasis in a murine model of breast cancer
    Y. E. Smith
    S. Toomey
    S. Napoletano
    G. Kirwan
    C. Schadow
    A. J. Chubb
    J. H. Mikkelsen
    C. Oxvig
    J. H. Harmey
    BMC Cancer, 18
  • [34] Comparison of Radioimmuno and Carbon Nanotube Field-Effect Transistor Assays for Measuring Insulin-Like Growth Factor-1 in a Preclinical Model of Human Breast Cancer
    Laundette P Jones
    Steingrimur Stefansson
    Man S Kim
    Saeyoung N Ahn
    Journal of Nanobiotechnology, 9
  • [35] ANTITUMOR RESPONSE AFTER VACCINATION TARGETING INSULIN GROWTH FACTOR BINDING PROTEIN 2 IN A SYNGENEIC MOUSE MODEL OF OVARIAN CANCER LOCALIZED BY THREE-DIMENSIONAL IN VIVO OPTICAL IMAGING
    Cecil, Denise L.
    Paragas, Neal
    Hitchcock-Bernhardt, Katie M.
    Disis, Mary L.
    Liao, John B.
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 188 - 188
  • [36] Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysis
    Logan, John G.
    Sophocleous, Antonia
    Marino, Silvia
    Muir, Morwenna
    Brunton, Valerie G.
    Idris, Aymen I.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (05) : 1229 - 1242
  • [37] Involvement of Insulin-Like Growth Factor-1 in Receptor Activator of Nuclear Factor Kappa-B Ligand-Targeted Therapy in Mouse Model of Lung Cancer Bone Metastasis
    Goto, H.
    Yamago, T.
    Saijo, A.
    Ogino, H.
    Tobiume, M.
    Otsuka, K.
    Kozai, H.
    Yoneda, H.
    Nokihara, H.
    Nishioka, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [38] Insulin/Insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21WAF1/Cip1
    Lai, A
    Sarcevic, B
    Prall, OWJ
    Sutherland, RL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) : 25823 - 25833
  • [39] The cyclin-dependent kinase inhibitor p21CIP/WAF is a positive regulator of insulin-like growth factor I-induced cell proliferation in MCF-7 human breast cancer cells
    Dupont, JL
    Karas, M
    LeRoith, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) : 37256 - 37264
  • [40] Stromal cells promote anti-estrogen resistance of breast cancer cells through an insulin-like growth factor binding protein 5 (IGFBP5)/B-cell leukemia/lymphoma 3 (Bcl-3) axis
    Leyh, Benjamin
    Dittmer, Angela
    Lange, Theresia
    Martens, John W. M.
    Dittmer, Juergen
    ONCOTARGET, 2015, 6 (36) : 39307 - 39328
12345